IRADIMED CORPORATION (IRMD)

IRADIMED CORPORATION Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	63.29	51.16	52.23	49.76	57.96	62
Short-Term Investments	-	-	-	-	-	0.5
Cash & Short-Term Investments	63.29	51.16	52.23	49.76	57.96	62.5
Cash Growth	11.96%	-2.06%	4.97%	-14.14%	-7.27%	20.25%
Receivables	13.67	13.67	10.56	12.22	13.27	5.14
Inventory	13.49	11.62	10.4	12.82	5.37	4.3
Prepaid Expenses	1.25	4.76	2.05	1.19	0.63	1
Other Current Assets	1.1	-	-	-	0.25	3.31
Total Current Assets	92.8	81.2	75.24	76	77.49	76.24
Property, Plant & Equipment	24.08	23.86	16.81	11.33	4.61	4.55
Other Intangible Assets	3.41	3.38	3.1	2.52	2.07	1.12
Long-Term Deferred Tax Assets	0.52	0.09	2.82	2.12	0.7	0.77
Other Long-Term Assets	-	0.24	0.35	0.18	0.65	0.2
Total Assets	121.07	108.78	98.33	92.16	85.51	82.88

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.42	1.82	1.9	1.86	1.8	0.78
Accrued Expenses	4.17	3.22	3.77	2.88	2.87	2.81
Current Portion of Leases	-	-	-	0.43	0.29	0.28
Current Income Taxes Payable	-	1.81	-	0.25	0.12	0.14
Current Unearned Revenue	3.57	2.87	2.26	2.57	3.37	2.55
Other Current Liabilities	0.16	0.46	0.58	8.34	0.09	0.26
Total Current Liabilities	10.32	10.18	8.51	16.33	8.55	6.82
Long-Term Leases	-	-	0	1.62	1.91	2.21
Long-Term Unearned Revenue	4.29	3.98	2.99	2.79	1.38	1.68
Total Liabilities	14.62	14.16	11.51	20.74	11.84	10.71

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	32.35	30.39	30.03	28.16	26.41	25.16
Retained Earnings	74.1	64.23	56.79	43.26	47.26	46.99
Comprehensive Income & Other	-	-	-	-	-	0.02
Shareholders' Equity	106.45	94.62	86.82	71.42	73.67	72.17
Total Liabilities & Equity	121.07	108.78	98.33	92.16	85.51	82.88

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	-	0	2.04	2.21	2.48
Net Cash (Debt)	63.29	51.16	52.23	47.72	55.76	60.02
Net Cash Growth	11.96%	-2.05%	9.46%	-14.41%	-7.10%	21.83%
Net Cash Per Share	4.92	3.98	4.09	3.75	4.41	4.77
Filing Date Shares Outstanding	12.79	12.78	12.72	12.66	12.59	12.56
Total Common Shares Outstanding	12.79	12.78	12.71	12.66	12.59	12.54
Working Capital	82.48	71.02	66.73	59.67	68.94	69.42
Book Value Per Share	8.32	7.40	6.83	5.64	5.85	5.75
Tangible Book Value	103.04	91.23	83.72	68.9	71.6	71.06
Tangible Book Value Per Share	8.06	7.14	6.59	5.44	5.69	5.66
Land	9.51	9.51	6.25	6.25	-	-
Buildings	11.58	11.53	-	-	-	-
Machinery	6.62	5.68	4.49	4.2	3.78	3.32
Construction In Progress	0	0.02	8.81	1.26	0.67	0.54
Leasehold Improvements	-	-	0.27	0.27	0.26	0.24

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error